Home/Altagenics/Kelly Ferraro

KF

Kelly Ferraro

Media Contact (River North Agency for GLD Partners)

Therapeutic Areas

Musculoskeletal Geriatrics Oncology Supportive Care Metabolic Disorders

Altagenics Pipeline

Drug	Indication	Phase
Discovery Program (Unnamed)	Sarcopenia (age-related muscle wasting)	Discovery

Leadership Team at Altagenics

Managing Director of GLD Partners LP (Founding Investor)

Dr. Martin Schiller

CEO of Heligenics (Technology Partner)

View full Altagenics profile